THE LIBRARY: WHITEPAPER
Too Big to Succeed: What's Next for Big Pharma?
The biopharmaceutical industry's largest companies have grown too large to offer shareholders a compelling return. L.E.K.'s analysis shows how pharma companies can address their most pressing challenges. Learn more
Latest Commentary
Henri Termeer rediscovers the 'Genzyme feel' in world of biotech startups
Which Big Biotechs are hitting the gas pedal on R&D spending?
MedImmune chief taps top prospects, hunts new biologics deals
Guidelines for contributing an Industry Voices column to Fierce
Hope to see you in Chicago for #BIO2013
more
EVENTS
- Clinical Diagnostics May 29 - 31, 2013
- DIA 2013 49th Annual MeetingJune 23-27 — Boston, MA
- BioImmersion Three-Day CourseOctober 16-18 — Washington, D.C.
Press Releases
- Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
- Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
- Statistical Challenges in Medical Device Trail Evaluation
- New drug enhances radiation treatment for brain cancer in preclinical studies
- Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S.
- More Press Releases
Featured Jobs
-
Senior Manager, API Development
Tesaro - Boston, MA -
Medical Writer
Tesaro - Boston, MA -
Director, Clinical Research & Development Job
Celgene Corporation - Warren Township NJ US -
Manager/Sr. Manager, Drug Product Development
Tesaro - Boston, MA -
Senior Director, IPD (Integrated Product Development)
PAREXEL International - Bethesda MD
